BioNavis Oy is a biotechnology startup based in Finland, founded in 2006. The company specializes in molecular interactions and surface characterization, offering MP-SPR Navi™ instruments, the only Multi-Parametric Surface Plasmon Resonance (MP-SPR) instruments on the market. BioNavis aims to assist professionals in life sciences, biosensors, and material sciences, providing real-time label-free surface-sensitive techniques for measuring molecular interactions, structural changes, and layer properties in both dry and wet states. The company is on a mission to develop Surface Plasmon Resonance (SPR) technology beyond current capabilities, manufacturing instruments with superior features and performance. BioNavis has introduced several firsts in the industry, including PureKinetics for high-quality kinetic data without bulk effect, measurements of nanoparticle/pharmaceutical drug uptake route label-free, and LayerSolver, a dedicated algorithm to calculate thickness and refractive index from multi-wavelength full SPR curves. BioNavis Oy's dedication to advancing SPR technology makes it an intriguing prospect for venture capitalists looking to invest in the biotechnology and health care sectors. With its innovative products and expertise, BioNavis has the potential to carve out a significant market share and deliver valuable solutions to professionals globally.
There is no investment information
No recent news or press coverage available for BioNavis Oy.
We care about your data, and we'd love to use cookies make your experience better.
